Three new Ebola vaccines are being developed: An infectious disease expert explains

Article excerpt

Three new Ebola vaccines are in development, buoyed by up to $62 million in fresh funding to accelerate candidates targeting the strain circulating in the Democratic Republic of the Congo and Uganda. The timing marks a rare convergence of positive momentum in infectious disease response, the funding announcement arrived alongside a separate piece of good news in the outbreak response effort. An infectious disease expert walks through what these vaccine candidates represent and their potential impact on containing future outbreaks in the region.